budesonide

(redirected from Entocort EC)
Also found in: Medical.
Translations
budesonid

budesonide

n budesonida, budesónida (INN)
References in periodicals archive ?
Bridgewater, New Jersey-based generic pharmaceutical manufacturer Amneal Pharmaceuticals has launched budesonide capsules, 3 mg, an AB-rated equivalent to Entocort EC, the company said.
Mayne Pharma Group Limited is pleased to announce the launch of a generic version of Entocort EC (budesonide capsules) 3mg in the United States.
This, in combination with the fact that US Mylan Inc (NASDAQ: MYL) recently launched a generic version of AstraZeneca's Crohn's disease drug Entocort EC, has made RBS lower its estimates for the Anglo-Swedish major.
114 Prometheus Entocort EC 65483070210 $307,212,524
Fortunately, with the FDA's approval of Entocort EC (budesonide) made by AstraZeneca, patients have more treatment options.
The company added Budesonide Capsules, 3 mg (Enteric Coated) is the generic version of AstraZeneca's Entocort EC capsules.
18 May 2010 - UK AstraZeneca PLC (LON: AZN) said today it has inked an agreement with Teva Pharmaceuticals USA Inc (formerly Barr Laboratories Inc) to settle patent litigation regarding Teva's proposed generic version of AstraZeneca's Entocort EC (budesonide) capsules.
18 May 2010 - Anglo-Swedish pharma major AstraZeneca (LON: AZN) (STO: AZN) and Israeli Teva Pharmaceutical Industries (NASDAQ: TEVA) announced today a settlement deal in a US patent trial regarding Teva's proposed generic version of AstraZeneca's Entocort EC capsules against Crohn's disease.
In five clinical trials, 48 to 69 percent of patients treated with Entocort EC (budesonide) capsules experienced significant clinical improvement after eight weeks.
The trials were not powered to show statistical differences between UCERIS and the reference arms (Asacol in the CORE I study and Entocort EC in CORE II).
In connection with the FDA's acceptance for filing of the UCERIS NDA, Santarus is providing notice to the NDA holder and the patent owner that UCERIS 9 mg does not infringe any claims of the one unexpired patent listed in the Orange Book for Entocort EC or that the claims in the patent are invalid.